A contemporary analysis of induction immunosuppression in pediatric lung transplant recipients

Transplant International

Volumn 27, Issue 2, 2014, Pages 211-218

  Hayes, Don ^a,b,c   Kirkby, Stephen ^a,b,c   Wehr, Allison M ^a   Lehman, Amy M ^a   McConnell, Patrick I ^a,c   Galantowicz, Mark ^a,c   Higgins, Robert S ^a   Whitson, Bryan A ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^c NATIONWIDE CHILDREN S HOSPITAL   (United States)

Author keywords

children; immunosuppression; induction; lung transplantation; pediatric lung transplantation; survival

Indexed keywords

ALEMTUZUMAB; BASILIXIMAB; BILIRUBIN; CREATININE; LYMPHOCYTE ANTIBODY; THYMOCYTE ANTIBODY;

ADOLESCENT; ALLOGRAFT; ARTICLE; BILIRUBIN BLOOD LEVEL; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CHILD; CLINICAL PRACTICE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CYSTIC FIBROSIS; DIABETES MELLITUS; DYING; GENDER; GRAFT FAILURE; GRAFT RECIPIENT; GRAFT SURVIVAL; HEART MUSCLE ISCHEMIA; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INDUCTION CHEMOTHERAPY; INFECTION; LUNG COMPLICATION; LUNG GRAFT REJECTION; LUNG INSUFFICIENCY; LUNG TRANSPLANTATION; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; NEOPLASM; ORGAN DONOR; PEDIATRIC SURGERY; PRESCHOOL CHILD; PRIORITY JOURNAL; RACE; SCHOOL CHILD; STEROID THERAPY; SURVIVAL TIME;

CHILDREN; IMMUNOSUPPRESSION; INDUCTION; LUNG TRANSPLANTATION; PEDIATRIC LUNG TRANSPLANTATION; SURVIVAL;

ADOLESCENT; ANTIBODIES, MONOCLONAL; ANTIBODIES, MONOCLONAL, HUMANIZED; ANTILYMPHOCYTE SERUM; CADAVER; CHILD; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; LUNG TRANSPLANTATION; MALE; PROPORTIONAL HAZARDS MODELS; RECOMBINANT FUSION PROTEINS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84892369206     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/tri.12240     Document Type: Article

References (25)

1. Benden C, Edwards LB, Kucheryavaya AY, et al,. The registry of the International Society for Heart and Lung Transplantation: fifteenth pediatric lung and heart-lung transplantation report-2012. J Heart Lung Transplant 2012; 31: 1087.
2. Estenne M, Maurer JR, Boehler A, et al,. Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria. J Heart Lung Transplant 2002; 21: 297.
3. Estenne M, Hertz MI,. Bronchiolitis obliterans after human lung transplantation. Am J Respir Crit Care Med 2002; 166: 440.
4. Khalifah AP, Hachem RR, Chakinala MM, et al,. Minimal acute rejection after lung transplantation: a risk for bronchiolitis obliterans syndrome. Am J Transplant 2005; 5: 2022.
5. Brock MV, Borja MC, Ferber L, et al,. Induction therapy in lung transplantation: a prospective, controlled clinical trial comparing OKT3, anti-thymocyte globulin, and daclizumab. J Heart Lung Transplant 2001; 20: 1282.
6. Sharples LD, McNeil K, Stewart S, Wallwork J,. Risk factors for bronchiolitis obliterans: a systematic review of recent publications. J Heart Lung Transplant 2002; 21: 271.
7. Burton CM, Iversen M, Carlsen J, et al,. Acute cellular rejection is a risk factor for bronchiolitis obliterans syndrome independent of post-transplant baseline FEV1. J Heart Lung Transplant 2009; 28: 888.
8. Parada MT, Alba A, Sepúlveda C,. Bronchiolitis obliterans syndrome development in lung transplantation patients. Transplant Proc 2010; 42: 331.
9. Martinu T, Howell DN, Palmer SM,. Acute cellular rejection and humoral sensitization in lung transplant recipients. Semin Respir Crit Care Med 2010; 31: 179.
10. Benden C, Faro A, Worley S, et al,. Minimal acute rejection in pediatric lung transplantation-does it matter? Pediatr Transplant 2010; 14: 534.
11. Horslen S, Barr ML, Christensen LL, Ettenger R, Magee JC,. Pediatric transplantation in the United States, 1996-2005. Am J Transplant 2007; 7: 1339.
12. Goldfarb SB, Gaynor JW, Fuller S, et al,. Induction therapy with antithymocyte globulin before reperfusion. Ann Thorac Surg 2010; 90: 1110; discussion 1114.
13. Palmer SM, Miralles AP, Lawrence CM, Gaynor JW, Davis RD, Tapson VF,. Rabbit antithymocyte globulin decreases acute rejection after lung transplantation: results of a randomized, prospective study. Chest 1999; 116: 127.
14. Cai J, Terasaki PI,. Induction immunosuppression improves long-term graft and patient outcome in organ transplantation: an analysis of United Network for Organ Sharing registry data. Transplantation 2010; 90: 1511.
15. United Network for Organ Sharing/Organ Procurement and Transplantation Network Standard Transplant Analysis and Research Database [January 23, 2013]. Available from: http://optn.transplant.hrsa.gov/data/about/OPTNDatabase.asp.
16. Hosmer DW Jr, Lemeshow S,. Applied Survival Analysis: Regression Modeling of Time to Event Data. New York: John Wiley & Sons Inc., 1999.
17. Hawksworth JS, Leeser D, Jindal RM, Falta E, Tadaki D, Elster EA,. New directions for induction immunosuppression strategy in solid organ transplantation. Am J Surg 2009; 197: 515.
18. Kirk AD,. Induction immunosuppression. Transplantation 2006; 82: 593.
19. Jaksch P, Wiedemann D, Augustin V, et al,. Antithymocyte globulin induction therapy improves survival in lung transplantation for cystic fibrosis. Transpl Int 2013; 26: 34.
20. Goggins WC, Pascual MA, Powelson JA, et al,. A prospective, randomized, clinical trial of intraoperative versus postoperative Thymoglobulin in adult cadaveric renal transplant recipients. Transplantation 2003; 76: 798.
21. Brennan DC, Daller JA, Lake KD, Cibrik D, Del Castillo D,. Thymoglobulin Induction Study Group. Rabbit antithymocyte globulin versus basiliximab in renal transplantation. N Engl J Med 2006; 355: 1967.
22. Ailawadi G, Smith PW, Oka T, et al,. Effects of induction immunosuppression regimen on acute rejection, bronchiolitis obliterans, and survival after lung transplantation. J Thorac Cardiovasc Surg 2008; 135: 594.
23. Hartwig MG, Snyder LD, Appel JZ 3rd, et al,. Rabbit anti-thymocyte globulin induction therapy does not prolong survival after lung transplantation. J Heart Lung Transplant 2008; 27: 547.
24. Hachem RR, Edwards LB, Yusen RD, Chakinala MM, Alexander Patterson G, Trulock EP,. The impact of induction on survival after lung transplantation: an analysis of the International Society for Heart and Lung Transplantation Registry. Clin Transplant 2008; 22: 603.
25. Grundy N, Simmonds J, Dawkins H, Rees P, Aurora P, Burch M,. Pre-implantation basiliximab reduces incidence of early acute rejection in pediatric heart transplantation. J Heart Lung Transplant 2009; 28: 1279.